The Japanese Journal of Gastroenterological Surgery
Online ISSN : 1348-9372
Print ISSN : 0386-9768
ISSN-L : 0386-9768
CASE REPORT
An Enteropathy-type Intestinal T-cell Lymphoma Showing Small-intestinal Perforation as Recurrence after Remission Due to Chemotherapy
Toshihito UeharaKaoru MiyashitaHideki NakatsukaNobuhiro MoriokaTetsuya ShimadaShintaro Fukuda
Author information
JOURNAL FREE ACCESS

2012 Volume 45 Issue 4 Pages 442-450

Details
Abstract
We report a case of enteropathy-type T-cell lymphoma recurring as a small intestine perforation after a remission of chemotherapy. A 64-year-old man with massive melena was referred to our hospital in November 2008. We performed emergency laparotomy and partial jejunectomy. Immunohistological examination demonstrated malignant lymphoma, NK/T-cell phenotype (CD3+, CD56+). After small bowel resection, he started to receive the CHOP regimen (cyclophosphamide, doxorubicin, vincristine and prednisolone) and achieved complete remission. However, he was admitted again with abdominal pain in February 2010. Computed tomography showed free air and ascites in the abdomen. Emergency laparotomy was performed after a diagnosis of small intestine perforation. During surgery we found a jejunal rupture, so we excised a part of the jejunum at this site. Immunohistologically, T-cell lymphoma was revealed again. Subsequent ileal rupture following jejunal rupture occurred, and the patient died of disseminated intravascular coagulation (DIC) after re-operation. The prognosis of enteropathy-type T-cell lymphoma is very poor, and it is a disease which should be given careful consideration.
Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc/4.0/deed.ja
Previous article Next article
feedback
Top